Recent Articles

July 16, 2018 8:06 am
Francis Crick Institute
Scientists have developed a technique that shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells the drug fails to reach.
July 16, 2018 6:00 am
Tommy Fanning, IDA Ireland
While single-use products have advantages in production costs and turnaround time, there are remain challenges for American biopharma companies when choosing their optimal overseas location.
July 12, 2018 5:00 am
Catherine Sbeglia
Vice President of strategy at D2 Consulting shares her thoughts on the direction of the pharmaceutical industry in light of the Trump Administration’s proposed crack down on prices, as well as what contributes to the high prices in the United States.
July 10, 2018 6:15 am
University of California - San Diego
Drug costs soar even as fewer patients are actually using the drugs.
July 6, 2018 9:23 am
Washington University School of Medicine
Increasing the number of potential targets for painkillers and including targets such as receptors on immune cells may make it possible to develop more effective painkilling drugs with fewer side effects, according to researchers.
June 15, 2018 12:46 pm
Mike Botta
The annual INTERPHEX Exhibitor Awards program, which is sponsored by Pharmaceutical Processing, recognizes companies that showcase creative technologies and/or new strategies and services that have significantly improved pharma and biopharma development and manufacturing.
June 25, 2018 5:10 am
Tokyo Medical and Dental University
Researchers found a promising lead compound to be a new intracellular delivery vehicle for therapeutically effective peptides.
June 21, 2018 5:10 am
European Molecular Biology Laboratory
The big challenge in cancer is that each patient's disease is different from a molecular point of view and has a unique set of molecular features that have led to its development, according to researchers.
June 20, 2018 5:00 am
University of Arizona Health Sciences
Under normal circumstances, BRCA keeps tumors at bay by repairing damaged DNA. However, a mutation in BRCA causes it to lose its tumor-suppressing abilities, increasing susceptibility to cancer.
June 19, 2018 5:30 am
Catherine Sbeglia
CEO of Quantuvis, a healthcare IT company, discusses how better and clearer communication between drug manufacturers and pharmacy benefit managers (PBMs) is a crucial part of the discussion.
Subscribe to Pharmaceutical Processing